SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids

BACKGROUND: Targeting viral cell entry proteins is an emerging therapeutic strategy for inhibiting the first stage of SARS-CoV-2 infection. In this study, 106 bioactive terpenoids from African medicinal plants were screened through molecular docking analysis against human angiotensin-converting enzy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyebi, Gideon A., Ogunyemi, Oludare M., Ibrahim, Ibrahim M., Ogunro, Olalekan B., Adegunloye, Adegbenro P., Afolabi, Saheed O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339396/
https://www.ncbi.nlm.nih.gov/pubmed/34351542
http://dx.doi.org/10.1186/s43141-021-00209-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339396/
https://www.ncbi.nlm.nih.gov/pubmed/34351542
http://dx.doi.org/10.1186/s43141-021-00209-z

Ejemplares similares